Literature DB >> 21207118

Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.

Einas M Al-Harbi1, Eman M Farid, Khalid A Gumaa, Emad M Masuadi, Jaipaul Singh.   

Abstract

Bahrain has one of the highest incidence rates of type 2 diabetes mellitus (T2DM). Development of diabetic nephropathy (DN) as a complication was noticed in some patients while absent in others. This interesting observation raises the role of certain genetic risk factors for the development of DN. Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism was found to be associated with T2DM. While some patients have predisposition to DN in the population, others have negative association. The present case-control association study was designed to investigate the association of ACE I/D polymorphism in T2DM patients in Bahrain especially in those who developed DN. A total of 360 T2DM patients (110 with DN and 250 without DN) and 360 healthy (non-diabetic) age-matched subjects were recruited for this study for comparison. The presence (insertion)/absence (deletion) (I/D) polymorphism of a 287-bp Alu1 element inside intron 16 of the ACE gene was investigated using PCR-gel electrophoresis. The results show that the distribution of the homozygote DD genotype of the ACE gene was high among Bahraini T2DM patients compared to the healthy non-diabetic subjects. In addition, the distribution of the deletion (D) allele was high among Bahraini T2DM patients with DN when compared to the healthy non-diabetic subjects. However, there was no significant difference in the distribution of ACE I/D allele and genotypes between DN patients when compared to those T2DM patients without DN. The results obtained in this study are in closely agreement with some previous reports which show a strong association of ACE polymorphism with T2DM patients, yet not a risk factor for development of DN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207118     DOI: 10.1007/s11010-010-0688-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  47 in total

1.  Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke.

Authors:  R Y Zee; P M Ridker; M J Stampfer; C H Hennekens; K Lindpaintner
Journal:  Circulation       Date:  1999-01-26       Impact factor: 29.690

2.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

Review 3.  Genetic determinants of type 2 diabetes.

Authors:  P Froguel; G Velho
Journal:  Recent Prog Horm Res       Date:  2001

4.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

5.  Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus.

Authors:  H Yoshida; S Kuriyama; Y Atsumi; H Tomonari; T Mitarai; A Hamaguchi; H Kubo; Y Kawaguchi; V Kon; K Matsuoka; I Ichikawa; O Sakai
Journal:  Kidney Int       Date:  1996-08       Impact factor: 10.612

6.  Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran.

Authors:  Alireza Esteghamati; Mohamad M Gouya; Mehrshad Abbasi; Alireza Delavari; Siamak Alikhani; Farishid Alaedini; Afshin Safaie; Mehrdad Forouzanfar; Edward W Gregg
Journal:  Diabetes Care       Date:  2007-10-05       Impact factor: 19.112

7.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

8.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

Authors:  K Lindpaintner; M A Pfeffer; R Kreutz; M J Stampfer; F Grodstein; F LaMotte; J Buring; C H Hennekens
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

9.  Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients.

Authors:  H Arzu Ergen; Husrev Hatemi; Bedia Agachan; Hakan Camlica; Turgay Isbir
Journal:  Exp Mol Med       Date:  2004-08-31       Impact factor: 8.718

10.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

View more
  7 in total

1.  Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects.

Authors:  Reza Meshkani; Hamzeh Saberi; Narges MohammadTaghvaei; Mohammad Amin Tabatabaiefar
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

2.  Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy.

Authors:  P Huo; D Zhang; X Guan; Y Mei; H Zheng; X Feng
Journal:  Mol Biol Rep       Date:  2014-09-17       Impact factor: 2.316

3.  Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism and Susceptibility of Minimal Change Nephrotic Syndrome: A Meta-Analysis.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Li-Na Su; Feng-Ying Lei; Wei-Fang Huang; Yan-Jun Zhao
Journal:  Int J Nephrol       Date:  2011-05-09

4.  Angiotensin-converting enzyme insertion/deletion polymorphism association with obesity and some related disorders in Egyptian females: a case-control observational study.

Authors:  Tarek K Motawi; Olfat G Shaker; Nancy N Shahin; Nancy M Ahmed
Journal:  Nutr Metab (Lond)       Date:  2016-10-12       Impact factor: 4.169

5.  The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.

Authors:  Yuying Wang; Wen Peng; Xiaoxue Zhang; Huibo Qiao; Li Wang; Zhigang Xu; Chenguang Wu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-09-15       Impact factor: 1.636

Review 6.  Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies.

Authors:  Chin Lin; Hsin-Yi Yang; Chia-Chao Wu; Herng-Sheng Lee; Yuh-Feng Lin; Kuo-Cheng Lu; Chi-Ming Chu; Fu-Huang Lin; Sen-Yeong Kao; Sui-Lung Su
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

7.  Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion.

Authors:  Işıl Kutluturk; Ali Karagöz; Tahir Bezgin; Vecih Oduncu; Ali Elveran; Cem Doğan; Ahmet Elbay; Cevat Kirma; Yusuf Ozertürk
Journal:  Thromb J       Date:  2014-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.